Aatru's technology platform includes a portable, wearable completely self-contained, negative pressure bandage that draws wound edges together, reducing wound exudate and promoting tissue formation, and a separate product designed to treat cosmetically damaged skin. The company anticipates compelling returns for investors through innovative thinking, design, and reduced cost to patients and healthcare providers. Aatru's NPSIMS™ product has received 510(k) FDA Clearance and has launched commercial sales in Latin America and the US, with the potential to be a market innovator with global market potential.